ReviewPharmaceuticals (Basel, Switzerland)2023

Niraparib and Advanced Ovarian Cancer: A Beacon in the Non-BRCA Mutated Setting.

Mauro Francesco Pio Maiorano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.